Home » Stocks » MLAB

Mesa Laboratories, Inc. (MLAB)

Stock Price: $291.78 USD 5.32 (1.86%)
Updated Jul 29, 2021 4:00 PM EDT - Market closed
Market Cap 1.50B
Revenue (ttm) 133.94M
Net Income (ttm) 3.27M
Shares Out 5.13M
EPS (ttm) 0.64
PE Ratio 455.91
Forward PE 35.21
Dividend $0.64
Dividend Yield 0.22%
Trading Day July 29
Last Price $291.78
Previous Close $286.46
Change ($) 5.32
Change (%) 1.86%
Day's Open 285.21
Day's Range 285.21 - 291.78
Day's Volume 36,297
52-Week Range 228.72 - 307.60

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

LAKEWOOD, Colo., July 06, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa Labs” or the “Company”) today announced that its Board of Directors has declared a regular qu...

3 weeks ago - GlobeNewsWire

CPB, MLAB, TMQ, CGAU, and BHVN have been added to the Zacks Rank #5 (Strong Sell) List on June 14, 2021

Other stocks mentioned: BHVN, CGAU, CPB, TMQ
1 month ago - Zacks Investment Research

Shares of Mesa Laboratories (NASDAQ:MLAB) were unchanged after the company reported Q4 results. Quarterly Results Earnings per share increased 53.49% year over year to $1.98, which beat the estimate of ...

1 month ago - Benzinga

LAKEWOOD, Colo., June 01, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the fourth quarter (“4Q21”) and full year ended March 31, 2021 (“FY21”).

1 month ago - GlobeNewsWire

Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

These seven small-cap stocks have the potential of rebounding and making it big in the post-pandemic reality of 2021. The post 7 Small-Cap Stocks To Buy for Their Big Ambitions appeared first on Investo...

Other stocks mentioned: EVER, HSKA, NWLI, PRTS, WINA
2 months ago - InvestorPlace

LAKEWOOD, Colo., April 05, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa Labs” or the “Company”) today announced that its Board of Directors has declared a regular q...

3 months ago - GlobeNewsWire

Mesa Labs (MLAB) delivered earnings and revenue surprises of -0.68% and 5.79%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

5 months ago - Zacks Investment Research

LAKEWOOD, Colo., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the third quarter (“3Q21”) and nine months ended December 31, 2020.

5 months ago - GlobeNewsWire

Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

5 months ago - Zacks Investment Research

LAKEWOOD, Colo., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa Labs” or the “Company”) today announced that its Board of Directors has declared a regular qu...

6 months ago - GlobeNewsWire

Mesa Labs (MLAB) delivered earnings and revenue surprises of 78.50% and 5.25%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

8 months ago - Zacks Investment Research

LAKEWOOD, Colo., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the second quarter (“2Q21”) and six months ended September 30, 2020.

8 months ago - GlobeNewsWire

Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

9 months ago - Zacks Investment Research

LAKEWOOD, Colo., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa Labs” or the “Company”) today announced that its Board of Directors has declared a regular qu...

9 months ago - GlobeNewsWire

Bear of the Day: Mesa Labs (MLAB)

10 months ago - Zacks Investment Research

The S&P 500 index saw its trailing 12-month revenue per share increase by approximately 4% every year over the past five years.

Other stocks mentioned: AAON, AMOT
11 months ago - GuruFocus

Mesa Labs (MLAB) delivered earnings and revenue surprises of -6.18% and -5.55%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

11 months ago - Zacks Investment Research

LAKEWOOD, Colo., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the first quarter (“1Q21”).

11 months ago - GlobeNewsWire

Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 year ago - Zacks Investment Research

Source:  Mesa Laboratories, Inc. – June 16, 2020 11:30 AM ET

1 year ago - GlobeNewsWire

Source: Mesa Laboratories, Inc. - June 9, 2020 8:15 PM ET

1 year ago - GlobeNewsWire

Source: Mesa Laboratories, Inc. – June 8, 2020 4:01 PM ET

1 year ago - GlobeNewsWire

Mesa Labs (MLAB) delivered earnings and revenue surprises of -36.45% and -0.85%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

Shares of Mesa Laboratories (NASDAQ:MLAB) were unchanged after the company reported Q4 results.

1 year ago - Benzinga

LAKEWOOD, Colo., June 01, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the fourth quarter (“4Q20”) and full year ended March 31, 2020 (“FY20”).

1 year ago - GlobeNewsWire

Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 year ago - Zacks Investment Research

LAKEWOOD, Colo., May 15, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced the election of Shannon Hall to its Board of Directors.  Shannon previously led the Life Science...

1 year ago - GlobeNewsWire

LAKEWOOD, Colo., Jan. 09, 2020 (GLOBE NEWSWIRE) --  Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quar...

1 year ago - GlobeNewsWire

Mesa Labs (MLAB) delivered earnings and revenue surprises of 0.58% and -1.79%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

LAKEWOOD, Colo., Oct. 31, 2019 (GLOBE NEWSWIRE) --  Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”), a diversified supplier of quality control instruments and consumables ...

1 year ago - GlobeNewsWire

Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 year ago - Zacks Investment Research

Mesa Labs (MLAB) delivered earnings and revenue surprises of 7.18% and 2.29%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

Mesa Laboratories Inc. is up almost 300 percent over the last 6 years.

2 years ago - Seeking Alpha

About MLAB

Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products in the United States, Europe, Asia, North America, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the den... [Read more...]

Industry
Scientific & Technical Instruments
Founded
1982
CEO
Gary Owens
Employees
506
Stock Exchange
NASDAQ
Ticker Symbol
MLAB
Full Company Profile

Financial Performance

In 2020, MLAB's revenue was $133.94 million, an increase of 13.81% compared to the previous year's $117.69 million. Earnings were $3.27 million, an increase of 84.14%.

Financial Statements

Analyst Forecasts

According to 5 analysts, the average rating for MLAB stock is "Hold." The 12-month stock price forecast is 286.67, which is a decrease of -1.75% from the latest price.

Price Target
$286.67
(-1.75% downside)
Analyst Consensus: Hold